Post Content Previous Post Caplin Point Q4 Results: Profit up 17% YoY, margin expands; ₹3 dividend declared Next Post Marksans Pharma arm secures UK health regulator nod for epilepsy treatment drug Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
